Shilpa CDMO Invests $50M in Peptide Capacity
The phased investment will add 10 kL of SPPS reactor capacity at its Raichur facility, beginning with a commercial manufacturing line scheduled to open in December
PR
By Priya Raman · Science Reporter
Nov 4 00:56 ETSource: Voice of Healthcare
From the source
Read at vohnetwork.comShilpa CDMO Invests $50M in Peptide Capacity
The phased investment will add 10 kL of SPPS reactor capacity at its Raichur facility, beginning with a commercial manufacturing line scheduled to open in December 2026.
